Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

ON THIS PAGEShared FeaturesCan You Have Both Psoriasis and RA?Which Do You Have?TreatmentWhen to See a RheumatologistPsoriasis and rheumatoid arthritis are both autoimmune diseases. While they affect ...

The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Rheumatoid arthritis RA not only affects joints but is also associated with stress and mental health issues Find out how to ...

Adverse drug reactions are more common in the liver than in the kidneys for patients with rheumatoid arthritis using ...

Netherlands: A new study published in Clinical Rheumatology has highlighted the risks associated with prolonged ...

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

The Rheumatoid Arthritis Drugs/Therapeutics market revenue was $$ Million USD in 2022, grew to $$ Million USD in 2024, and will reach $$ Million USD in 2032, with a CAGR of $% during 2024-2032.

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.